Bachem Holding AG
SIX:BANB

Watchlist Manager
Bachem Holding AG Logo
Bachem Holding AG
SIX:BANB
Watchlist
Price: 67.5 CHF -3.3% Market Closed
Market Cap: 5.1B CHF
Have any thoughts about
Bachem Holding AG?
Write Note

Bachem Holding AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bachem Holding AG
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bachem Holding AG
SIX:BANB
Revenue
CHf577.8m
CAGR 3-Years
8%
CAGR 5-Years
14%
CAGR 10-Years
13%
Siegfried Holding AG
SIX:SFZN
Revenue
CHf1.3B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Revenue
CHf6.7B
CAGR 3-Years
19%
CAGR 5-Years
4%
CAGR 10-Years
6%
Tecan Group AG
SIX:TECN
Revenue
CHf1B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Revenue
€324.9m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Revenue
CHf320m
CAGR 3-Years
19%
CAGR 5-Years
119%
CAGR 10-Years
N/A
No Stocks Found

Bachem Holding AG
Glance View

Market Cap
5.1B CHF
Industry
Life Sciences Tools & Services

Bachem Holding AG engages in the provision of peptides and oligonucleotides. The company is headquartered in Bubendorf, Basel-Landschaft and currently employs 1,639 full-time employees. The company went IPO on 2001-06-29. The firm focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The firm markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

BANB Intrinsic Value
90.95 CHF
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Bachem Holding AG's Revenue?
Revenue
577.8m CHF

Based on the financial report for Jun 30, 2024, Bachem Holding AG's Revenue amounts to 577.8m CHF.

What is Bachem Holding AG's Revenue growth rate?
Revenue CAGR 10Y
13%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Bachem Holding AG have been 8% over the past three years , 14% over the past five years , and 13% over the past ten years .

Back to Top